Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Equivalence: In Vitro and In Vivo Bioequivalence01:17

Equivalence: In Vitro and In Vivo Bioequivalence

Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...
Comparison Tests01:28

Comparison Tests

An infinite series composed of positive terms may either approach a finite value or increase without bound. Determining which outcome occurs is a central task in calculus, and comparison tests provide structured methods for making this determination. Rather than evaluating a series directly, these tests relate it to another series whose behavior is already known, allowing conclusions to be drawn through logical comparison.The direct comparison test applies to series with positive terms. If each...
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and Cox...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identifying Minimum Threshold Level of Trial Crossover Rates Yielding Nonsignificant Overall Survival Benefit Associated with Cancer Treatments: A Systematic Literature Review of HTA Submissions.

Journal of health economics and outcomes research·2026
Same author

Interobserver agreement when using a four-point mobility scoring system to score dairy cattle from video footage.

The Veterinary record·2026
Same author

Increasing Buprenorphine and Naloxone Access in Texas Community Pharmacies Through an Academic Detailing Intervention.

Substance use & addiction journal·2026
Same author

Epidemiological Shifts in Visceral Leishmaniasis Incidence, Relapse, and Mortality in Brazil, 2007-2023: Analysis Using the National Notifiable Diseases Information System.

Open forum infectious diseases·2026
Same author

Impact of Transition from Compassionate to Scheduled Dialysis on Quality of Life for Patients at a Federally Qualified Health Center.

Journal of health care for the poor and underserved·2025
Same author

Cardioprotective effectiveness of SGLT2 inhibitors in older diabetic women with early-stage breast cancer following anthracycline- and/or trastuzumab-based treatment.

Therapeutic advances in medical oncology·2025

Related Experiment Video

Updated: Jun 10, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

Evaluating equivalence and noninferiority trials.

Anandaroop Dasgupta1, Kenneth A Lawson, James P Wilson

  • 1Center for Pharmacoeconomic Studies, Division of Pharmacy Administration, College of Pharmacy, University of Texas at Austin, 2409 University Avenue, Austin, TX 78712, USA.

American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
|August 7, 2010
PubMed
Summary

This study clarifies the design and interpretation of equivalence and non-inferiority trials, crucial for comparative effectiveness research. Understanding these trial types ensures accurate evaluation of treatment alternatives.

More Related Videos

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Experiment Videos

Last Updated: Jun 10, 2026

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

  • Clinical Trials Methodology
  • Biostatistics
  • Comparative Effectiveness Research

Background:

  • Comparative effectiveness research (CER) evaluates treatment alternatives using large, prospective, randomized controlled trials (RCTs).
  • Superiority trials, common in Phase III RCTs, aim to establish one treatment's advantage over another.
  • Understanding different trial designs is essential for interpreting treatment comparisons.

Purpose of the Study:

  • To describe conceptual issues in designing equivalence and non-inferiority trials.
  • To outline considerations for interpreting the findings of these specific trial designs.
  • To differentiate equivalence and non-inferiority trials from traditional superiority trials.

Main Methods:

  • Discussion of conceptual frameworks for equivalence and non-inferiority trial design.
  • Analysis of statistical testing associated with different trial types.
  • Review of interpretation guidelines for non-inferiority and equivalence study results.

Main Results:

  • Equivalence trials test if two treatments perform identically within a defined range.
  • Non-inferiority trials assess if a new treatment is not worse than a standard treatment.
  • A nonsignificant superiority test does not imply treatment similarity; equivalence trials are needed for this.

Conclusions:

  • Equivalence and non-inferiority trials possess distinct designs compared to superiority trials.
  • The quality of equivalence and non-inferiority studies hinges on robust study design and transparent reporting.
  • Non-inferiority trials allow preference for a test therapy if it offers secondary benefits (e.g., cost, safety).